CRYOCHECK™ CLOT C
||Conditioning||Package size ||
|CCC-15||2 x 5 x 1,5 mL||150 ||
|CCC-30||2 x 5 x 3,0 mL||300 ||
Clot-based assay intended for the quantitative determination of protein C activity in citrated human plasma.
cryocheck™ Clot C functions by direct activation of protein C in the patient sample using Protein C Activator. The common pathway of coagulation is initiated with a Russell’s viper venom (RVV-X) reagent to convert factor X to Xa and bypassing all factors above the common pathway. Patients with a protein C deficiency or dysfunction will have shortened cryocheck Clot C clotting times relative to patients with normal levels of functional protein C. The clotting time is proportional to the amount of functional protein C in the patient’s plasma and this can be quantified using a calibration curve.
- Protein C Deficient Plasma
- Clot C Activator (+ C & S Diluent)